The members of the Management and Therapy Subcommittee undertook an evidence-
based review of current dry eye therapies and management options. Management options …

Platelet-rich plasma (PRP) has recently become the focus of intensive interest and
discussion, in part because of the expanding understanding of platelet function. Anucleate …

The use of blood derivatives represents an alternative therapeutic approach that is gaining
interest in regenerative medicine due to its potential to stimulate and accelerate tissue …

The healing of vascularized mammalian tissue injuries initiate with hemostasis and clotting
as part of biological defense system leading to the formation of a fibrin clot in which activated …

Dry eye disease (DED) represents a heterogeneous group of conditions with tear film
insufficiency and signs and/or symptoms of ocular surface irritation. The clinical …

Dry eye syndrome (DES) is multifactorial and likely to be a cause of concern more so than
ever given the rapid pace of modernization, which is directly associated with many of the …

Autologous serum (AS) eye drops was the first blood-derived product used for the treatment
of corneal pathologies but nowadays PRGF arises as a novel interesting alternative to this …

Introduction The objective of this study was to evaluate the use of autologous platelet-rich
plasma (PRP) eye drops as monotherapy for the treatment of moderate to severe cases of …

The corneal epithelium serves to protect the underlying cornea from the external
environment and is essential for corneal transparency and optimal visual function …

PRP is a portion of the patient's own blood having a platelet concentration above baseline.
The main advantage of PRP over other products is the presence of the platelets and …